Return on Tangible Equity (Annual)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

Axsome Therapeutics, Inc. (AXSM) had Return on Tangible Equity of -512.60% for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$638.50M
Net Income	$-183.17M
Cost of Goods Sold	$47.48M
Gross Profit	$591.02M
Operating Expenses	$805.26M
Operating Income	$-166.76M
Non-Operating Income/Expense	$-16.94M
Pre-Tax Income	$-183.70M
Normalized Pre-Tax Income	$-183.70M
Income after Taxes	$-183.17M
Income from Continuous Operations	$-183.17M
Consolidated Net Income/Loss	$-183.17M
Normalized Income after Taxes	$-183.17M
EBIT	$-166.76M
EBITDA	$-156.40M
Weighted-Average Shares Outstanding (Basic)	49.75M
Weighted-Average Shares Outstanding (Diluted)	49.75M
Earnings per Share (EPS) (Basic)	$-3.68
Earnings per Share (EPS) (Diluted)	$-3.68
Balance Sheet Financials
Current Assets	$588.99M
Property, Plant, and Equipment	$0.56M
Long-Term Assets	$100.82M
Total Assets	$689.80M
Current Liabilities	$378.84M
Long-Term Debt	$121.95M
Long-Term Liabilities	$222.67M
Total Liabilities	$601.51M
Common Equity	$88.29M
Tangible Shareholders Equity	$35.73M
Shareholders Equity	$88.30M
Common Shares Outstanding	50.88M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-93.41M
Cash Flow from Investing Activities	$-0.48M
Cash Flow from Financial Activities	$101.47M
Beginning Cash	$315.35M
End Cash	$322.93M
Increase/Decrease in Cash	$7.58M
Stock-Based Compensation	$93.75M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.55
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.58
Debt to Equity Ratio	2.17
Gross Margin	92.56%
Operating Margin	-26.12%
EBIT Margin	-26.12%
EBITDA Margin	-24.49%
Pre-Tax Profit Margin	-28.77%
Profit Margin	-28.69%
Free Cash Flow	$-93.89M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.93
Inventory Turnover	1.70
Receiveable Turnover	2.84
Days Sales in Receivables	128.32
Return on Equity	-207.46%
Return on Tangible Equity	-512.60%
Return on Assets	-26.55%
Return on Investments	-87.12%
Book Value Per Share	$1.74
Free Cash Flow per Share	$-1.89
Operating Cash Flow per Share	$-1.88

Data from Zacks Investment Research, Inc.